SANA BIOTECHNOLOGY INC (SANA) Stock Balance Sheet
NASDAQ:SANA - Nasdaq - US7995661045 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 96.13M | 127.57M | 133.52M | 176.80M | 253.00M | |||
| Marketable Securities | 8.57M | 24.93M | 71.68M | 247.20M | 298.00M | |||
| Other Current Assets | 8.03M | 8.31M | 8.32M | 20.50M | 7.10M | |||
| Total Current Assets | 112.73M | 160.81M | 213.51M | 444.40M | 558.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 128.52M | 135.27M | 145.59M | 159.40M | 161.80M | |||
| Investments And Advances | N/A | N/A | 0.00 | 10.10M | 195.90M | |||
| Goodwill | 140.63M | 140.63M | 140.63M | 140.60M | 140.60M | |||
| Intangibles | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | |||
| Other Non-Current Assets | 4.39M | 5.12M | 6.37M | 9.00M | 13.80M | |||
| Total Non-Current Assets | 332.74M | 340.21M | 351.78M | 378.30M | 571.30M | |||
| TOTAL ASSETS | 445.47M | 501.02M | 565.30M | 822.70M | 1.13B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 30.63M | 38.47M | 57.70M | 50.40M | 38.20M | |||
| Accounts Payable | 989.00K | 5.21M | 4.11M | 2.90M | 2.20M | |||
| Other Current Liabilities | 1.54M | 1.75M | 2.68M | 58.20M | 58.80M | |||
| Total Current Liabilities | 33.16M | 45.43M | 64.49M | 111.50M | 99.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 203.24M | 205.08M | 213.31M | 211.90M | 301.70M | |||
| Total Non-Current Liabilities | 203.24M | 205.08M | 213.31M | 211.90M | 301.70M | |||
| TOTAL LIABILITIES | 236.39M | 250.52M | 277.79M | 323.40M | 400.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.65B | -1.60B | -1.34B | -1.05B | -785.40M | |||
| Additional Paid In Capital | 1.86B | 1.86B | 1.63B | 1.56B | 1.52B | |||
| Common Shares | 23.00K | 22.00K | 20.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 0.00 | 14.00K | -60.00K | -4.30M | -1.40M | |||
| Shares Outstanding | 225.46M | 223.92M | 197.86M | 191.00M | 184.90M | |||
| Tangible Book Value per Share | 0.04 | 0.23 | 0.44 | 1.57 | 2.86 | |||
| Total Shareholders' Equity | 209.08M | 250.50M | 287.51M | 499.30M | 728.50M | |||
| TOTAL LIABILITIES AND EQUITY | 445.47M | 501.02M | 565.30M | 822.70M | 1.13B | |||
| Statistics | ||||||||
| Current Ratio | 3.40 | 3.54 | 3.31 | 3.99 | 5.63 | |||
| Return On Assets (ROA) | -46.84% | -53.24% | -50.11% | -32.76% | -31.51% | |||
| Return On Equity (ROE) | -99.81% | -106.49% | -98.52% | -53.97% | -48.86% | |||
All data in USD , ROIC based on taxRate of 0.21